Nebivolol STELLA 5 mg

Rx

Indications:

Treatment of hypertension.

Dosage:

• Adults: The dose is one tablet (5 mg) daily, preferably at the same time of the day.
• Patients with renal insufficiency, patients over 65 years: the recommended starting dose is 2.5 mg daily. If needed, the daily dose may be increased to 5 mg.

Usage:

Nebivolol STELLA 5 mg is administered orally.

• Known hypersensitivity to any of the active substance or excipients.
• Liver insufficiency or liver function impairment.
• Acute heart failure, cardiogenic shock or episodes of heart failure decompensation requiring i.v. inotropic therapy.
• Sick sinus syndrome, including sino-atrial block.
• Second and third degree heart block (without a pacemaker).
• History of bronchospasm and bronchial asthma.
• Metabolic acidosis.
• Untreated phaeochromocytoma.
• Bradycardia (heart rate < 60 bpm prior to start therapy).
• Hypotension (systolic blood pressure < 90 mmHg)

Headache, dizziness, paresthesia, dyspnea, constipation, nausea, diarrhea, tiredness and edema.

• The beta-adrenergic antagonist should be discontinued at least 24 hours before surgery.
• Beta-adrenergic antagonists should not be used in patients with untreated congestive heart failure, unless their condition has been stabilized.
• In patients with ischemic heart disease, treatment with a beta-antagonist should be discontinued gradually, i.e. over 1 – 2 weeks.
• Beta-adrenergic antagonists should be used with caution In patients with Raynaud’s disease or syndrome, intermittent claudication; patients with first degree heart block, Prinzmetal’s angina; diabetic patients and patients with chronic obstructive pulmonary disorders.
• Nebivolol should not be used during pregnancy unless clearly necessary. Administration of nebivolol is not recommended during breastfeeding.
• Patients should be aware of how they react to drug before driving or operating machinery as dizziness and fatigue may occasionally occur.